UK researchers have found that weight loss drugs like Ozempic may reduce deadly complications following heart attacks by improving blood flow in small heart vessels. The findings are based on animal studies, with experts emphasising that human trials are required before these GLP-1 drugs can be implemented in emergency cardiac care.